• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Cadila gets USFDA nod for depression tab Risperidone

      Posted AtNewkerala.com

      Mumbai, Oct 20 : Pharmaceutical company Cadila Healthcare today said that its parent firm Zydus Cadila has received US Food and Drug Administration (USFDA) approval to market Risperidone Tablets, used to treat depression.

      Risperidone falls in the central nervous system (CNS) segment, Cadila Healthcare stated in a filing to the Bombay Stock Exchange.

      The group now has 41 approvals and has so far filed for 79 Abbreviated New Drug Application's (ANDA), it added.

      Last week, Zydus Cadila filed an Investigational New Drug application with the Drugs Controller General of India for ZYT 1, which is used to prevent heart attack and stroke.

      Shares of the Company were trading at Rs 258, down 2.69 per cent in the noon session on the Bombay Stock Exchange.

      October 29, 2008


      Share this Article!

    Back to top^